NCT03165084

Brief Summary

The aim of this study is to develop and evaluate a person-centred digital intervention in primary healthcare for people with T2D, in addition to their usual diabetes care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 5, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 24, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

May 24, 2017

Status Verified

May 1, 2017

Enrollment Period

1.1 years

First QC Date

May 5, 2017

Last Update Submit

May 22, 2017

Conditions

Keywords

Self-managementPrimary Health CareeHealth

Outcome Measures

Primary Outcomes (1)

  • HbA1c

    Change from baseline in HbA1c at 6 months and 1 year (in mmol/mol)

    Baseline, 6 months, and 12 months

Secondary Outcomes (12)

  • Systolic blood pressure

    Baseline, 6 months, and 12 months

  • Body Mass Index

    Baseline, 6 months, and 12 months

  • Waist circumference

    Baseline, 6 months, and 12 months

  • Cholesterol, total, LDL and HDL

    Baseline, 6 months, and 12 months

  • Lifestyle habits - physical activity

    Baseline, 6 months, and 12 months

  • +7 more secondary outcomes

Study Arms (3)

Intervention arm

EXPERIMENTAL

Participants in the intervention group will receive usual care, and also use a diabetesapp and a homepage and advice personally tailored according to the personal needs to provide support for them to manage e.g. food choices, exercise, medicine, blood sugars and emotional adaptation.

Behavioral: Intervention arm: Person-centred interactive self-management support

Control arm

OTHER

Participants in the control group will receive usual care and also take part in a minimal intervention in the form of a brochure on the importance of self-management in diabetes.

Other: Control arm

External comparison group

OTHER

An external comparison group will be recruited from two other primary health care centers in order to analyse possible Hawthorne effects.

Other: External comparison group

Interventions

Person-centred tailored digital self-management support hypothesised to decrease HbA1c, improve other metabolic measurements, improve lifestyle habits, and increase diabetes empowerment, increase diabetes-dependent quality of life, improve illness perception, and improve eHealth literacy. Access to the diabetes mobile application and the homepage during 16 weeks. Each individual will set personal goals for use of the digital resources.

Intervention arm

Participants will receive usual care and take part in a minimal intervention in the form of a brochure on the importance of self-management in diabetes.

Control arm

External comparison groups in order to analyse possible Hawthorne effects.

External comparison group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with type 2 diabetes within the last five years
  • years of age or older
  • Ability to read and communicate in Swedish
  • Own a smart phone

You may not qualify if:

  • Life-threatening physical illness (e.g. cancer)
  • Documented cognitive impairment
  • Those not responsible for their own self care
  • Those not residing in their own home environment (e.g. those in nursing homes, in-patient hospital wards)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nursing, Umeå University

Umeå, 901 87, Sweden

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Åsa Hörnsten, Professor

    Umeå University

    STUDY DIRECTOR

Central Study Contacts

Ulrika Öberg, RN, MSc, PhD student

CONTACT

Åsa Hörnsten, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc, PhD student

Study Record Dates

First Submitted

May 5, 2017

First Posted

May 24, 2017

Study Start

May 5, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

May 24, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations